pamidronate has been researched along with Myelodysplastic Syndromes in 1 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
Excerpt | Relevance | Reference |
---|---|---|
" Bone densitometry is particularly effective for early detection of patients at risk for fracture and is of practical interest since patients with osteoporosis can now be treated with Pamidronate." | 3.71 | [Bone evaluation in ten adults with cutaneous mastocytosis]. ( Armingaud, P; Benhamou, CL; Estève, E; Kerdraon, R; Lespessailles, E; Petavy-Catala, C; Zerkak, D, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armingaud, P | 1 |
Zerkak, D | 1 |
Lespessailles, E | 1 |
Petavy-Catala, C | 1 |
Kerdraon, R | 1 |
Benhamou, CL | 1 |
Estève, E | 1 |
1 other study available for pamidronate and Myelodysplastic Syndromes
Article | Year |
---|---|
[Bone evaluation in ten adults with cutaneous mastocytosis].
Topics: Adult; Anti-Inflammatory Agents; Bone Density; Bone Diseases; Bone Diseases, Metabolic; Bone Marrow | 2002 |